#United States #Rochester #Healthcare Leadership #Mayo Clinic #Dr. Callstrom

Mayo Clinic Welcomes New Leadership

In a significant leadership transition, the Mayo Clinic Board of Trustees has elected Dr. Matthew R. Callstrom, M.D., Ph.D., as its new president and CEO. This change comes as Dr. Gianrico Farrugia, M.D., prepares to step down on December 31, 2026, after leading the organization since 2019. The Board expressed confidence in Dr. Callstrom, citing his extensive experience and commitment to the Clinic's mission.

Dr. Callstrom has been a member of the Mayo Clinic family since 2002, where he has built a distinguished career across multiple disciplines including patient care, research, and healthcare innovation. His roles have spanned clinical practice leadership, strategic development, and the integration of artificial intelligence into medical practices. His proven ability to harness scientific advancements to enhance patient outcomes positions him well to navigate the Clinic into its next chapter.

Richard K. Davis, chair of the Mayo Clinic Board of Trustees, remarked on Dr. Callstrom’s extensive background and leadership skills, saying, "Dr. Callstrom is an accomplished physician-scientist and enterprise leader who brings nearly 25 years of experience at Mayo Clinic and a deep commitment to our values and mission."

As he steps into this pivotal role, Dr. Callstrom aims to amplify Mayo Clinic’s impact on patient care through innovation and collaborative efforts. In his words, "Mayo Clinic has always been at its best when we bring the full power of our clinical expertise, science, and innovation to the needs of the patient. Now, we have an opportunity to build on that foundation."

Dr. Callstrom’s unique expertise lies at the intersection of patient care, science, and technological advancement. Renowned for his contributions to image-guided cancer treatments, he has published over 200 papers and holds several patents. His previous leadership roles include serving as interim chief strategy officer and as chair of the Department of Radiology at the Mayo Clinic in Rochester.

Prior to his upcoming presidency, Dr. Callstrom served as medical director for the Mayo Clinic Strategy and the AI Program, where he played a crucial role in promoting the responsible integration of AI in healthcare. His vision for Mayo Clinic involves accelerating the translation of scientific discovery into actionable patient care strategies while enhancing the Clinic's capacity to deliver high-quality service to patients whether they visit in person or seek telehealth options.

Dr. Callstrom succeeds Dr. Farrugia, who led a transformative era for Mayo Clinic. Under Dr. Farrugia’s leadership, the Clinic launched its Bold. Forward. strategy, focused on leveraging technology to advance healthcare and improve patient experiences. Davis praised Dr. Farrugia’s tenure: "His leadership has strengthened Mayo Clinic and created tremendous momentum for the future. The Board is deeply grateful for Dr. Farrugia's continued service and contributions."

In his own reflections, Dr. Farrugia expressed confidence in Dr. Callstrom’s capabilities, stating, "Dr. Callstrom knows Mayo Clinic deeply, understands where healthcare is headed, and has the vision and experience to build on the progress we have made."

With Dr. Callstrom at the helm, the Mayo Clinic is poised to continue its legacy of excellence in patient-centered care and scientific innovation, embodying the commitment to healing and advancing health on a global scale. This leadership change signals exciting possibilities for the future of healthcare, fostering a culture of collaboration and innovation that will benefit patients around the world.